12-111446611-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_005475.3(SH2B3):​c.733-142T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.204 in 565,604 control chromosomes in the GnomAD database, including 12,557 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.20 ( 3042 hom., cov: 32)
Exomes 𝑓: 0.21 ( 9515 hom. )

Consequence

SH2B3
NM_005475.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.277

Publications

10 publications found
Variant links:
Genes affected
SH2B3 (HGNC:29605): (SH2B adaptor protein 3) This gene encodes a member of the SH2B adaptor family of proteins, which are involved in a range of signaling activities by growth factor and cytokine receptors. The encoded protein is a key negative regulator of cytokine signaling and plays a critical role in hematopoiesis. Mutations in this gene have been associated with susceptibility to celiac disease type 13 and susceptibility to insulin-dependent diabetes mellitus. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014]
ATXN2 (HGNC:10555): (ataxin 2) This gene belongs to a group of genes that is associated with microsatellite-expansion diseases, a class of neurological and neuromuscular disorders caused by expansion of short stretches of repetitive DNA. The protein encoded by this gene has two globular domains near the N-terminus, one of which contains a clathrin-mediated trans-Golgi signal and an endoplasmic reticulum exit signal. The encoded cytoplasmic protein localizes to the endoplasmic reticulum and plasma membrane, is involved in endocytosis, and modulates mTOR signals, modifying ribosomal translation and mitochondrial function. The N-terminal region of the protein contains a polyglutamine tract of 14-31 residues that can be expanded in the pathogenic state to 32-200 residues. Intermediate length expansions of this tract increase susceptibility to amyotrophic lateral sclerosis, while long expansions of this tract result in spinocerebellar ataxia-2, an autosomal-dominantly inherited, neurodegenerative disorder. Genome-wide association studies indicate that loss-of-function mutations in this gene may be associated with susceptibility to type I diabetes, obesity and hypertension. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
ATXN2 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 12-111446611-T-C is Benign according to our data. Variant chr12-111446611-T-C is described in ClinVar as [Benign]. Clinvar id is 1281022.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.325 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SH2B3NM_005475.3 linkc.733-142T>C intron_variant Intron 2 of 7 ENST00000341259.7 NP_005466.1 Q9UQQ2Q59H48

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SH2B3ENST00000341259.7 linkc.733-142T>C intron_variant Intron 2 of 7 1 NM_005475.3 ENSP00000345492.2 Q9UQQ2
SH2B3ENST00000538307.1 linkc.127-142T>C intron_variant Intron 1 of 6 2 ENSP00000440597.1 F5GYM4
ATXN2ENST00000642389.2 linkn.*171-2424A>G intron_variant Intron 26 of 26 ENSP00000496055.2 A0A2R8Y7E6

Frequencies

GnomAD3 genomes
AF:
0.195
AC:
29673
AN:
151972
Hom.:
3041
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.166
Gnomad AMI
AF:
0.151
Gnomad AMR
AF:
0.175
Gnomad ASJ
AF:
0.109
Gnomad EAS
AF:
0.338
Gnomad SAS
AF:
0.275
Gnomad FIN
AF:
0.185
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.207
Gnomad OTH
AF:
0.211
GnomAD4 exome
AF:
0.207
AC:
85637
AN:
413514
Hom.:
9515
AF XY:
0.209
AC XY:
45085
AN XY:
215320
show subpopulations
African (AFR)
AF:
0.160
AC:
1873
AN:
11670
American (AMR)
AF:
0.158
AC:
2381
AN:
15076
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
1326
AN:
12730
East Asian (EAS)
AF:
0.280
AC:
7991
AN:
28518
South Asian (SAS)
AF:
0.273
AC:
9909
AN:
36332
European-Finnish (FIN)
AF:
0.187
AC:
6172
AN:
33072
Middle Eastern (MID)
AF:
0.295
AC:
644
AN:
2182
European-Non Finnish (NFE)
AF:
0.202
AC:
50388
AN:
249954
Other (OTH)
AF:
0.207
AC:
4953
AN:
23980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
3063
6125
9188
12250
15313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
360
720
1080
1440
1800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.195
AC:
29680
AN:
152090
Hom.:
3042
Cov.:
32
AF XY:
0.194
AC XY:
14456
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.166
AC:
6880
AN:
41462
American (AMR)
AF:
0.175
AC:
2676
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
380
AN:
3472
East Asian (EAS)
AF:
0.339
AC:
1744
AN:
5152
South Asian (SAS)
AF:
0.275
AC:
1324
AN:
4814
European-Finnish (FIN)
AF:
0.185
AC:
1960
AN:
10608
Middle Eastern (MID)
AF:
0.306
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
0.207
AC:
14046
AN:
67966
Other (OTH)
AF:
0.209
AC:
442
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1228
2456
3685
4913
6141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
328
656
984
1312
1640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.203
Hom.:
382
Bravo
AF:
0.193
Asia WGS
AF:
0.301
AC:
1048
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.3
DANN
Benign
0.77
PhyloP100
-0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28362508; hg19: chr12-111884415; COSMIC: COSV57986513; COSMIC: COSV57986513; API